28 maj: Prospekt – Kapitalforeningen Blue Strait Capital
28 maj: Novo Nordisk A/S - aktietilbagekøbsprogram
28-05-2018 12:41:14

Share buy-back week 21/2018

Relateret indhold
Relateret debat
12 jul - 
Det med analytikere.. Sad selv i aktieafdelingen i en a..
12 jul - 
Næ… det er da rigtigt nok, så l&aeli..
12 jul - 
Tillykke til dem med prisen. Dejligt med en form for be..

Announcement

            

28 May 2018

Coloplast – transactions in connection with share buy-back programme

As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up to DKK 1bn. This part of the programme of DKK500m is expected to take place from 26 February, 2018 to 25 August, 2018.

The buy-back programme will be structured in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Regulation 2016/1052, also referred to as the "Safe Harbour" rules, which ensure that the company is protected against violation of insider legislation in connection with the buyback programme.

The following transactions have been executed during the period 22 – 25 May 2018:

Date

Number of shares

Buying price

Amount DKK

22 May 2018

 14,061612.998,619,213.02

23 May 2018

 13,950611.988,537,180.99

24 May 2018

 30,330614.1818,627,976.28

25 May 2018

 19,625615.1212,071,745.70

Accumulated until now under the programme

 

 939,304

 

532.31

 

499,998,333.29

Henceforth, Coloplast owns 4,144,348 treasury B shares of DKK 1 equal to 1.92% of the company’s total share capital.

An overview showing the transaction data for the period 22 – 25 May 2018 is enclosed.

The first part of Coloplast’s share buy-back programme initiated 26 February 2018 (see Announcement No. 3/2018) is hereby finalized.

Kind regards,

Investor Relations

Coloplast A/S

Tel. +45 4911 1800

For further information, please contact

Investors and analyst

s                                             

Ellen Bjurgert

Director, Investor Relations

Tel. +45 4911 1800/+45 4911 3376

Email: dkebj@coloplast.com

Rasmus Sørensen

Sr. Manager, Investor Relations

Tel. +45 4911 1800/ +45 4911 1786

Email: dkraso@coloplast.com

                                                                                       

Press and the media                                                  

Lina Danstrup

Sr. Media Relations Manager

Tel. 4911 2607

Email: dklina@coloplast.com

This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ about 11,000 people.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2018-05 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.

Attachments

Primary Logo

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
12 jul
COLO-B
Kan se du har skrevet i min tidligere tråd skrev præcist det samme (link i hovedteksten). Siden er a..
2
12 jul
COLO-B
  Jeg skrev i maj (se Tidligere tråd ) at Coloplast måske ville bryde 4 års konsolidering og gå mod ..
2
12 jul
COLO-B
Realisten2: Jeg evaluere dag for dag. Som skrevet ovenfor virker markedet ikke særlig bekymret ved e..
1
12 jul
COLO-B
Arhh pas nu på at vi ikke bliver for sensitive. Der er blevet sagt det der var værre herinde og iøvr..
1
12 jul
COLO-B
Nu er prisdannelsen heldigvis markedets samlede mening og over de seneste måneder virker det til at ..
1
12 jul
COLO-B
Jeg fornemmer en halvsur mavefornemmelse ovre ved dig over årets stigning, men må indrømme at jeg ha..
1
12 jul
COLO-B
Coloplast har været plaget af nogle trælse sager, som såvidt jeg er orienteret, er kommet ud af syst..
1

Fondsbørsmeddelelser

#

EuroInvestor: I fokus
#

#

EuroInvestor: I fokus
#

#

EuroInvestor: I fokus
#

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/UBS: Indleder med købsanbefaling og ser aktien stige 37 pct.
2
Novo/ABM: Recepttal understøtter forventning om opjustering
3
Genmab/Jefferies: Darzalex øger tilliden til ledelsens forventninger
4
Aktier/tendens: Genmab og kolleger får udlandsnyt i let nervøs åbning
5
Aktier/åbning: Vestas fører an i positivt C25-indeks

Relaterede aktiekurser

Coloplast B A/S 666,00 0,2% Stigning i aktiekurs
Coloplast 101,75 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Seneste nyheder


Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. juli 2018 02:58:03
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180712.1 - EUROWEB3 - 2018-07-18 02:58:03 - 2018-07-18 02:58:03 - 1 - Website: OKAY